ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1512	National Cancer Institute	Html	en	Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of osteosarcoma/malignant fibrous histiocytoma of bone.	cancer treatment 0.407081 malignant tumor cells 0.349447 body 0.457542 type 0.332048 chemotherapy 0.334597 PDQ cancer information 0.39878 clinical trial search 0.334862 clinical trials 0.824706 Pediatric Treatment Editorial 0.299208 cancer information summary 0.360916 clinical trial 0.498576 kinase inhibitor therapy 0.337105 detailed pictures 0.314561 patients 0.324824 NCI PDQ cancer 0.313063 radiation therapy 0.384486 Treatment Editorial Board 0.303904 bone cancer 0.343085 treatment 0.712766 wide local excision 0.303347 magnetic resonance imaging 0.301911 new cancer treatments 0.298777 osteosarcoma cells 0.305575 NCI-supported cancer 0.30089	cancer cells 0.508672 standard treatment 0.304104 Cancer Information Service 0.301597 MFH 0.338322 specific cancer cells 0.314742 Recurrent osteosarcoma 0.349728 patient 0.335989 treatment clinical trials 0.338171 National Cancer Institute 0.390929 effects cancer treatment 0.325995 new treatment 0.35734 treatment clinical trial 0.302675 bone 0.549956 primary tumor 0.351503 nuclear magnetic resonance 0.304246 PDQ summary 0.321698 cancer clinical trials 0.368405 Combination chemotherapy 0.30296 tumor 0.52585 cancer information summaries 0.299038 comprehensive cancer information 0.299274 cancer 0.934486 osteosarcoma 0.560059 surgery 0.417923	CLICK HERE
1874	National Cancer Institute	Html	es	Tratamiento de los tumores extragonadales de células germinativas (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores extragonadales de células germinativas.	germ-cell tumors 0.383819 metastatic germ 0.316138 germ-cell tumors with 0.328427 residual mass 0.330871 Nichols CR 0.459486 Greco FA 0.321626 initial salvage therapy 0.319174 largo plazo 0.317683 following systemic chemotherapy 0.321834 with germ-cell tumors 0.328027 malignant germ-cell tumors 0.322658 single-institution experience with 0.326215 unknown primary site 0.318402 germ cell tumours 0.337125 Extragonadal germ 0.317435 Cell Cancer Collaborative 0.335481 Hainsworth JD 0.322365 cell or non-germ 0.330347 Williams SD 0.32023 salvage treatment 0.337434 high-dose chemotherapy 0.334497 Instituto Nacional 0.329901 International Germ Cell 0.371979 Tumores mixtos 0.340879 Advanced poorly differentiated 0.316704	cell malignancy after 0.327663 primary mediastinal nonseminomatous 0.349396 unrecognized germ 0.316359 patients with 0.426473 Kramar A 0.320119 germ cell neoplasms 0.33799 disseminated germ 0.332449 Einhorn LH 0.38746 Germ Cell Consensus 0.341019 effective chemotherapy regimen 0.321136 Salvage chemotherapy 0.319709 germ cell 0.988418 PDQ Tratamiento 0.334355 extragonadal nonseminomatous germ 0.321388 Indiana University 0.317574 Clin Oncol 0.830939 as salvage treatment 0.323614 mediastinal germ-cell tumors 0.323089 mediastinal nonseminomatous germ 0.353563 postchemotherapy residual mass 0.322319 germ cell tumors 0.75596 Catalano PJ 0.324048 Oncology Group 0.318284 germ cell cancer 0.426267	CLICK HERE
1923	National Cancer Institute	Html	es	Tratamiento del melanoma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del melanoma.	almacena agua 0.234953 siguientes procedimientos 0.33648 estadio iv 0.436307 siguientes aspectos 0.242705 CTLA-4.Ampliar Inhibidor 0.229258 genes braf 0.219515 pequeña cantidad 0.22974 siguientes tipos 0.26039 estadios ia 0.227409 ganglio linfático centinela 0.971469 rayos x 0.230817 estadio ib 0.421722 estadio ia 0.418874 enlace drugs approved 0.315654 células t 0.340582 luz solar 0.830082 PD-1.Ampliar Inhibidor 0.228522 vitamina d 0.235166	National Cancer Institute 0.217987 lunar atípico 0.239383 Instituto Nacional 0.232974 estadios iia 0.230643 PDQ Tratamiento 0.658062 melanoma causa efectos 0.315066 antecedentes familiares 0.293778 cabo pruebas 0.278327 estadio iia 0.421244 estadio iic 0.418402 PDQ Exámenes 0.269726 Physician Data Query 0.266129 lápiz mide 0.244567 estadio iii 0.594614 siguientes situaciones 0.233677 panel derecho 0.258009 siguientes pruebas 0.238893 melanoma ocular uveal 0.435674	CLICK HERE
1929	National Cancer Institute	Html	es	Tratamiento del carcinoma de sitio primario desconocido (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer metastásico que se diseminó desde un sitio primario desconocido.	PDQ Tratamiento 0.503744 siguientes procedimientos 0.523984 alta potencia 0.503524 siguientes elementos 0.505673 siguientes aspectos 0.504431 Physician Data Query 0.507109 coriónica humana beta 0.506354 radioterapia externa causa 0.507986 tumor primario oculto.Ampliar 0.520296 siguientes razones 0.505928 siguientes tipos 0.504856	vía oral 0.502538 rayos x 0.503516 sitio primario desconocido 0.964151 Sudores nocturnos 0.504661 cuáles pruebas 0.503677 numerosos ensayos 0.506292 National Cancer Institute 0.501623 siguientes riesgos 0.501356 células cancerosas ayuda 0.516934 Instituto Nacional 0.503286	CLICK HERE
1980	National Cancer Institute	Html	es	Tratamiento del sarcoma de Ewing (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de la familia del sarcoma de Ewing.	Cirujano oncólogo 0.631512 siguientes procedimientos 0.653106 células madre 0.978655 adultos jóvenes 0.637237 faja ajustadora 0.638641 vía oral 0.627826 rayos x 0.63487 estudio tipos 0.620537 enlace drugs approved 0.646857 niño ayuda 0.64117 células t 0.686984 efectos tardíos 0.851996 PDQ Efectos tardíos 0.679663 Ewing extraóseo 0.77445 National Cancer Institute 0.625093 IRMN).Ampliar Imágenes 0.631059	encontrarlo.ampliar exploración 0.638439 ortopedista oncólogo 0.633744 Instituto Nacional 0.644246 PDQ Tratamiento 0.658351 determinados cambios 0.617816 Ewing causa efectos 0.748473 presente sección 0.621848 explorador tep 0.641296 nuevos tipos 0.626452 Physician Data Query 0.690644 Soft Tissue Sarcoma 0.727359 diseminó.ampliar aspiración 0.638694 quimioterapia sistémica forma 0.678849 leucemia mieloide aguda 0.649605 tumor óseo 0.67804 siguientes pruebas 0.708113	CLICK HERE
3450	National Cancer Institute	Html	en	Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Health Professional Version	Expert-reviewed information summary about the preparation needed by health care providers, patients, and families for the transition to end-of-life care in advanced cancer.	lung cancer 0.641373 Cancer patient preferences 0.503664 American Cancer Society 0.471339 palliative care cohort 0.487911 health care providers 0.49452 advance care planning 0.617548 Cancer Care Outcomes 0.545737 Care Outcomes Research 0.519676 colorectal cancer 0.485035 ill hospitalized patients 0.478763 incurable cancer patients 0.49288 breast cancer patients 0.489402 patients 0.763742 cancer patients 0.59867 elderly cancer patients 0.49242 EOL health care 0.473964 incurable cancer 0.495495 decision making 0.513832 metastatic breast cancer 0.474641 et al. 0.585917 care 0.714724 end-of-life care 0.494853 treatment 0.487292 palliative care interventions 0.478305 study 0.52262	Palliative care communication 0.477608 metastatic non-small-cell lung 0.492002 Palliat Support Care 0.474344 palliative care 0.683174 PUBMED Abstract 0.539791 Hosp Palliat Care 0.499255 treatment preferences 0.470843 Support Care Cancer 0.520243 advanced lung cancer 0.489792 advanced colorectal cancer 0.478138 palliative oncology care 0.483778 lung cancer patients 0.527648 early palliative care 0.566869 Intern Med 0.533629 preferences 0.530446 advanced cancer 0.753385 advance directives 0.485421 Abstract 0.690455 Clin Oncol 0.911079 Arch Intern Med 0.488878 medical care 0.489903 randomized controlled trial 0.484267 health care decisions 0.476382 cell lung cancer 0.493742	CLICK HERE
3566	National Cancer Institute	Html	en	Training	NCI offers training at laboratories and clinics in Maryland and at universities and institutions nationwide. These cancer training and career development opportunities cover a broad spectrum of disciplines for individuals at career stages ranging from high school and graduate students to scientists, clinicians, and health care professionals.	National Cancer Institute 0.966549		CLICK HERE
14597	National Cancer Institute	Html	en	Common Cancer Myths and Misconceptions	The latest science-based information concerning some common misconceptions about cancer. Learn the facts to worry less and make good health decisions.	cancer treatment 0.293552 multiple family members 0.287169 different surgical tools 0.292574 best studies 0.351264 wrong ideas 0.256786 individual cancer patient 0.352232 Cancer patients 0.292909 artificial sweeteners 0.340098 Cancer Vaccines 0.299159 bladder cancer 0.291637 good prevention 0.259057 Cancer Risk 0.329552 tobacco smoke 0.287568 environmental factors 0.290117 Risk Factors 0.292696 magnetic energy 0.286101 complementary therapies 0.281474 person 0.354916 cancers 0.347867 Five-year survival rates 0.302006 common cancer myths 0.360301 Metastatic Cancer 0.322576 Annual Report 0.258223 NCI fact sheet 0.996571 United States 0.312478	excess weight gain 0.296228 cancer cells 0.333742 5-year survival rate 0.300282 Helicobacter pylori 0.298521 personal hair dye 0.285054 natural result 0.291706 Hereditary Cancer Syndromes 0.328419 cell phones 0.296722 scientific evidence 0.293613 No. Researchers 0.257042 needless worry 0.25947 old theories 0.256313 transplant-related cancer 0.304436 NCI fact sheets 0.326267 Botanicals/Herbal Products section 0.288672 No. 0.263456 Breast Cancer 0.289863 medicine products—including vitamins 0.287253 latest science-based information 0.32382 power lines 0.324548 thyroid cancers 0.300398 Certain popular ideas 0.304234 cancer 0.824886 information 0.40326	CLICK HERE
15646	National Cancer Institute	Html	en	Grants Management Contacts	null	LIPSCOMB UNIVERSITY UTTER 0.614715 UNIVERSITY HEALTH SCIENCES 0.625816 MEDICAL CENTER WALTERS 0.616396 STATE UNIVERSITY PRITCHARD 0.643659 HOWARD UNIVERSITY KEARSE 0.605096 STATE UNIVERSITY COFIE 0.614592 MEDICAL CENTER 0.875732 BROWN UNIVERSITY KEARSE 0.615759 CAROLINA STATE UNIVERSITY 0.619853 STATE UNIVERSITY SALO 0.669411 STATE UNIVERSITY KNOWLES 0.615594 STATE UNIVERSITY KEARSE 0.653523 UNIVERSITY HEALTH 0.637053 STATE UNIVERSITY MONTES 0.717388 AMERICAN UNIVERSITY SOWELL 0.638565 ATLANTIC UNIVERSITY KEARSE 0.609604 STATE UNIVERSITY MEININGER 0.613395 RESEARCH INSTITUTE 0.777493 ALABAMA STATE UNIVERSITY 0.62296 BAYLOR UNIVERSITY PRITCHARD 0.613283 UNIVERSITY CHICAGO NGUYEN 0.608201 STATE UNIVERSITY HICKMAN 0.625736 MCGILL UNIVERSITY UTTER 0.611917 STATE UNIVERSITY MITCHELL 0.672133 STATE UNIVERSITY NGUYEN 0.639382	RESERVE UNIVERSITY KEARSE 0.613085 cancer research 0.608564 UNIVERSITY MEDICAL CAMPUS 0.61532 CHICAGO STATE UNIVERSITY 0.608015 DUQUESNE UNIVERSITY WALTERS 0.608895 STATE UNIVERSITY 0.98856 STATE UNIVERSITY WONG 0.676901 LINDA UNIVERSITY UTTER 0.613669 MEDICAL CENTER MONTES 0.63558 MEDICAL UNIVERSITY SOWELL 0.63184 UNIVERSITY HEALTH CTR 0.621136 ARIZONA UNIVERSITY MONTES 0.636738 CALIFORNIA STATE UNIVERSITY 0.645138 UNIVERSITY WALTERS 0.616172 UNIVERSITY KEARSE 0.654785 RESEARCH INSTITUTE MONTES 0.613304 AMERICAN UNIVERSITY MONTES 0.657637 STATE UNIVERSITY SACRAMENTO 0.604248 STATE UNIVERSITY REIS 0.609221 CLARKSON UNIVERSITY MONTES 0.653016 FLORIDA STATE UNIVERSITY 0.608756 STATE UNIVERSITY UTTER 0.65066 STATE UNIVERSITY BAILEY 0.715208 UNIVERSITY MEDICAL CENTER 0.735227	CLICK HERE
16448	National Cancer Institute	Html	en	Identifying Novel Drug Combinations to Overcome Treatment Resistance	A review of current research identifying and testing drug combination approaches that have the potential to overcome or delay resistance to cancer treatment.	cancer treatment 0.25347 cancer cell lines—a 0.280999 healthy cells 0.296062 novel drug combinations 0.308632 lung cancer 0.280527 chemotherapy resistance 0.310051 cancer drug resistance 0.46496 Kettering Cancer Center 0.280587 effective drug pairs 0.26607 clinical trials 0.313646 epigenetic alterations 0.2886 original drug 0.25941 molecular alterations 0.297668 myeloid cells 0.309525 ovarian cancer 0.356692 cisplatin resistance 0.289204 patients 0.50622 immune checkpoint inhibitors 0.342594 single tumor 0.262236 Nature Reviews Cancer 0.299509 potential drug combinations 0.282064 tumor—contain molecular alterations 0.269672 combination treatment approach 0.285984 multidrug resistance section 0.355811 drug resistance 0.805264	cancer drugs 0.296242 treatment 0.450602 Cancer Research UK 0.305072 ABC transporter inhibitors 0.39367 chemotherapy drugs 0.281313 breast cancer tumors 0.293816 cancer cells 0.926321 cancer cell lines 0.386565 so-called intrinsic resistance 0.362006 epigenetic alteration 0.261391 Dana-Farber Cancer Institute 0.280545 Dr. Gottesman 0.323556 DNA methylation 0.280984 Cancer Research 0.350827 ABC transporters 0.47073 Hospital Cancer Center 0.277242 epigenetic codes—molecular modifications 0.267446 cancer researchers 0.266263 inactivating T cells 0.270905 drugs 0.323984 ovarian cancer cell 0.296997 drug combinations 0.458324 tumor microenvironment 0.309626 lung cancer cell 0.275824	CLICK HERE